Clinical Trial Update: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing inhaled furosemide for dyspnea due to bronchiolitis in mustard gas-exposed patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Drugs mentioned

• Furosemide inhalation (furosemide)

Snippet

Sponsor: Baqiyatallah Medical Sciences University | Conditions: Bronchiolitis | Phase 3 | Status: COMPLETED